| DC Field | Value | Language |
|---|
| dc.contributor.author | Mirzoyan, R. S. | - |
| dc.contributor.author | Ganshina, T. S. | - |
| dc.contributor.author | Kurdyumov, I. N. | - |
| dc.contributor.author | Maslennikov, D. V. | - |
| dc.contributor.author | Gnezdilova, A. V. | - |
| dc.date.accessioned | 2022-05-06T13:38:00Z | - |
| dc.date.available | 2022-05-06T13:38:00Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Migraine pharmacology and brain ischemia / R.S. Mirzoyan [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №2.-P. 67-82. - Doi: 10.3897/rrpharmacology.7.67463. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46641 | - |
| dc.description.abstract | The aim of this review article was to analyze in details the mechanism of drugs’ effects in the treatment and prevention of a migraine attack, as well as to discuss the hypotheses of migraine pathogenesis | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | drugs for migraine treatment | ru |
| dc.subject | migraine | ru |
| dc.subject | ischemic brain damage | ru |
| dc.subject | new anti-ischemic | ru |
| dc.subject | anti-serotoninergic drugs | ru |
| dc.title | Migraine pharmacology and brain ischemia | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 2
|
